Home
>
US Stocks
>
AlloVir Inc
AlloVir Inc
ALVR

AlloVir Inc

$21.814.98%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
22.26
Today Low/High
21.8 / 22.26
52 Week Low/High
$16.66 / $48.96
Market Cap
$1.19B

Company Details

AlloVir is a leading late clinical-stage cell therapy company with a focus on restoring natural immunity against life-threatening viral diseases in patients with severely weakened immune systems. The company’s innovative and proprietary technology platforms leverage off-the-shelf, allogeneic, multi-virus specific T cells targeting devastating viruses for patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases. AlloVir’s technology and manufacturing process enables the potential for the treatment and prevention of a spectrum of devastating viruses with each single allogeneic cell therapy. The company is advancing multiple mid- and late-stage clinical trials across its product portfolio.
Organisation
AlloVir Inc
Employees
53
Industry
Health Technology

Discover more

Frequently Asked Questions

What is AlloVir Inc share price today

Can Indians buy AlloVir Inc shares?

How can I buy AlloVir Inc shares from India?

Can Fractional shares of AlloVir Inc be purchased?

What are the documents required to start investing in AlloVir Inc stocks?

We are a SEBI registered investement advisor